The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
"Performance for these companies continues to be supported by competitive advantages, strong balance sheets, robust free cash generation, and consistently high returns on capital," Schoenstein said.
Strategically, he favors businesses with exposure to positive secular trends such as aging demographics.
"We are focused on healthcare companies that supply innovation-focused products and can benefit from volume increases both domestically and throughout the world, " Schoenstein said.
A name he likes now is UnitedHealth Group. "UnitedHealth has posted consistently high returns on equity and has used its robust free cash flow to continue to grow its business, including strategic acquisitions, as well as to return over $18.1 billion to shareholders via dividends and share buybacks over the last five years," Schoenstein said.
UnitedHealth is down during trading, but is up 17 percent over the past year.